Eubulus Biotherapeutics
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- Undisclosed
Investors
- 3
About Eubulus Biotherapeutics
Based in Jiaxing, China, and founded in 2018, Eubulus Biotherapeutics Inc. is a pharmaceutical company engaged in targeted protein degradation technology. The company's founder Dr, Xiaodong Cao graduated from Peking University, he has experience in protein structure-assisted small molecule drug design and molecular conjugates drug research and development. The core members of the R & D team have more than 20 years of drug development experience. The company is committed to developing cell and tissue-targeted protein degradation drugs, that can be applied in tumor treatment. The company focuses on solving the problem of poor drug properties of molecules and provides a solution for the transformation of protein degradation technology in drugs.
Who invested in Eubulus Biotherapeutics
3 investors across 1 round
See all investors in Eubulus Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 12, 2021
Amount
Undisclosed
Investors
Questions about Eubulus Biotherapeutics
Who invested in Eubulus Biotherapeutics?
Eubulus Biotherapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eubulus Biotherapeutics raised?
Eubulus Biotherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eubulus Biotherapeutics last raise money?
Eubulus Biotherapeutics's most recent round on record is a Series A, in Oct 2021.
What does Eubulus Biotherapeutics do?
Based in Jiaxing, China, and founded in 2018, Eubulus Biotherapeutics Inc.
Where is Eubulus Biotherapeutics headquartered?
Eubulus Biotherapeutics is headquartered in Jiaxing, China.
Which VCs invest in companies like Eubulus Biotherapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Eubulus Biotherapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Eubulus Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.